Evidence map›Paper›PMID 28369510›Full record

ArticleMolecular biology and evolution2017

Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function.

Amanda L Evans, Jack W D Blackburn, Kyle Taruc, Angela Kipp, Brennan S Dirk, Nina R Hunt, Stephen D Barr, Jimmy D Dikeakos, Bryan Heit

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology and evolution, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Mechanism of efferocytosis in atherosclerosis.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
  4. Article
  5. Article
  6. Defective efferocytosis of vascular cells in heart disease.Frontiers in cardiovascular medicine · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Quantification of Efferocytosis by Single-cell Fluorescence Microscopy.Journal of visualized experiments : JoVE · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Amanda L EvansDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Jack W D BlackburnDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Kyle TarucDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Angela KippDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Brennan S DirkDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Nina R HuntDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Stephen D BarrDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Jimmy D DikeakosDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Bryan HeitDepartment of Microbiology and Immunology and the Centre for Human Immunology, The University of Western Ontario, London, Canada.
Western University · CA

Funding

CIHR HBF134179CIHR HBF137693CIHR MOP-123419CIHR MOP-286719
6 · The paper itself

Abstract

TYRO3, AXL, and MERTK (TAM) receptors are a family of receptor tyrosine kinases that maintain homeostasis through the clearance of apoptotic cells, and when defective, contribute to chronic inflammatory and autoimmune diseases such as atherosclerosis, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and Crohn's disease. In addition, certain enveloped viruses utilize TAM receptors for immune evasion and entry into host cells, with several viruses preferentially hijacking MERTK for these purposes. Despite the biological importance of TAM receptors, little is understood of their recent evolution and its impact on their function. Using evolutionary analysis of primate TAM receptor sequences, we identified strong, recent positive selection in MERTK's signal peptide and transmembrane domain that was absent from TYRO3 and AXL. Reconstruction of hominid and primate ancestral MERTK sequences revealed three nonsynonymous single nucleotide polymorphisms in the human MERTK signal peptide, with a G14C mutation resulting in a predicted non-B DNA cruciform motif, producing a significant decrease in MERTK expression with no significant effect on MERTK trafficking or half-life. Reconstruction of MERTK's transmembrane domain identified three amino acid substitutions and four amino acid insertions in humans, which led to significantly higher levels of self-clustering through the creation of a new interaction motif. This clustering counteracted the effect of the signal peptide mutations through enhancing MERTK avidity, whereas the lower MERTK expression led to reduced binding of Ebola virus-like particles. The decreased MERTK expression counterbalanced by increased avidity is consistent with antagonistic coevolution to evade viral hijacking of MERTK.

Indexed as

AnimalsApoptosisAxl Receptor Tyrosine KinaseBase SequenceCell Movementc-Mer Tyrosine KinaseEvolution, MolecularHomeostasisHumansPhylogenyPolymorphism, Single NucleotidePrimatesProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesSignal TransductionAXL protein, humanAxl Receptor Tyrosine Kinasec-Mer Tyrosine KinaseMERTK protein, humanProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesTYRO3 protein, humanantagonistic coevolutionefferocytosisMERTKpositive selectionTAM receptorsviral infection

Identifiers

PMID28369510
PMCPMC5850725
OpenAlexW2600767498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.